The microglial immunoreceptor tyrosine‐based motif‐Syk signaling pathway is a promising target of immunotherapy for Alzheimer's disease is a research paper published in Clinical and Translational Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P30AR073752
National Institutes of Health
Grant: RF1AG05148501
NIA NIH HHS
Grant: RF1 AG059082
NIH HHS
Grant: R21 AG059176
National Institutes of Health
Grant: 5R21AG059176-02
IMPACT OF NOVEL REGULATORS OF TREM2 EXPRESSION ON ALZHEIMER'S DISEASE
National Institutes of Health
Grant: 1RF1AG059082-01A1
THERAPEUTIC STRATEGIES FOR ALZHEIMER'S DISEASE BASED ON TREM2 BIOLOGY
National Institutes of Health
Grant: 5P30AR073752-02
Washington University Rheumatic DiseasesResearch Resource-based Center
Cure Alzheimer's Fund
Fields of Study
MeSH Terms
Keywords
Additional file 1 of SYK promotes the formation of neutrophil extracellular traps by inducing PKM2 nuclear translocation and promoting STAT3 phosphorylation to exacerbate hepatic ischemia-reperfusion injury and tumor recurrence
Additional file 1 of SYK promotes the formation of neutrophil extracellular traps by inducing PKM2 nuclear translocation and promoting STAT3 phosphorylation to exacerbate hepatic ischemia-reperfusion injury and tumor recurrence